Sign inGet started

Forman Mark S

Insider CIK 1922353 · PASG Chief Medical Officer · VTYX Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VTYX Ventyx Biosciences, Inc. D To issuer deriv2026-03-042026-03-04350,000— $00SEC↗
VTYX Ventyx Biosciences, Inc. D To issuer deriv2026-03-042026-03-0485,000— $00SEC↗
VTYX Ventyx Biosciences, Inc. D To issuer2026-03-042026-03-046,000— $00SEC↗
VTYX Ventyx Biosciences, Inc. A Award2025-11-172025-11-193,000$1.03 $3.1K6,000SEC↗
VTYX Ventyx Biosciences, Inc. A Award2025-05-152025-05-163,000$1.03 $3.1K3,000SEC↗
VTYX Ventyx Biosciences, Inc. A Award deriv2025-01-022025-01-0385,000— $085,000SEC↗
VTYX Ventyx Biosciences, Inc. A Award deriv2024-08-122024-08-13350,000— $0350,000SEC↗
PASG Passage BIO, Inc. A Award deriv2024-03-152024-03-19203,000— $0203,000SEC↗
PASG Passage BIO, Inc. S Sale2024-02-132024-02-131,638$0.97 $1.6K48,631SEC↗
PASG Passage BIO, Inc. M Exercise deriv2024-02-102024-02-135,000— $010,000SEC↗
PASG Passage BIO, Inc. M Exercise2024-02-102024-02-135,000— $050,269SEC↗
PASG Passage BIO, Inc. S Sale2024-01-022024-01-0315,813$0.91 $14.4K45,269SEC↗
PASG Passage BIO, Inc. M Exercise deriv2023-12-312024-01-0350,000— $00SEC↗
PASG Passage BIO, Inc. M Exercise2023-12-312024-01-0350,000— $061,082SEC↗
PASG Passage BIO, Inc. A Award deriv2023-03-152023-04-05175,000— $0175,000SEC↗
PASG Passage BIO, Inc. A Award deriv2022-11-102022-11-1450,000— $050,000SEC↗
PASG Passage BIO, Inc. A Award deriv2022-06-132022-06-15136,000— $0136,000SEC↗
PASG Passage BIO, Inc. A Award deriv2022-04-182022-04-20136,000— $0136,000SEC↗
PASG Passage BIO, Inc. A Award deriv2022-02-102024-02-1325,000— $025,000SEC↗
PASG Passage BIO, Inc. A Award deriv2022-02-102024-02-1315,000— $015,000SEC↗
PASG Passage BIO, Inc. A Award deriv2021-08-162024-02-13130,000— $0130,000SEC↗